| mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |